Ionis Pharmaceuticals Inc
IONS· Nasdaq
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q4 2014 | Q4 2013 | Q4 2012 | Q4 2011 |
|---|---|---|---|---|
| Revenue | $84.86M | $42.25M | $19.87M | $32.40M |
| Net Income | $31.05M | -$24.28M | — | — |
| EPS Diluted | $0.25 |
Ionis Pharmaceuticals Inc · CIK 874015 · Engraved from SEC EDGAR
| -$0.21 |
| -$0.03 |
| -$0.20 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.